重性抑郁障碍风险变异的调控机制研究
该研究采用功能基因组学方法系统刻画重性抑郁障碍(MDD)风险变异的调控机制。通过整合人脑组织或神经元细胞的ChIP-Seq与PWM数据,识别出34个破坏15种转录因子结合的MDD风险SNP,并用报告基因实验、等位基因特异性表达分析和CRISPR-Cas9基因组编辑验证其调控效应。eQTL分析确定了这些调控性风险SNP可能调控的靶基因,并发现受rs3101339调控的NEGR1在MDD患者脑中表达失调,提示该SNP可能通过影响NEGR1表达 confer MDD风险。
要点
- 34个MDD风险SNP破坏15种转录因子结合,经多种实验验证调控效应。
- eQTL分析识别调控性风险SNP的靶基因,NEGR1在MDD患者脑中表达失调。
- rs3101339可能通过影响NEGR1表达 confer MDD风险,为机制研究和药物开发提供候选。
核心结论
- MDD风险变异通过影响转录因子结合和基因调控 confer 疾病风险。
- 研究识别了潜在MDD因果变异及其靶基因,为未来机制研究和药物开发提供关键候选。
研究设计与样本
- 采用功能基因组学方法,整合人脑组织或神经元细胞的ChIP-Seq数据与位置权重矩阵(PWM)数据。
- 使用报告基因实验、等位基因特异性表达分析和CRISPR-Cas9介导的基因组编辑验证转录因子结合破坏性SNP的调控效应。
- 通过表达数量性状基因座(eQTL)分析识别调控性风险SNP的靶基因。
主要发现
- 识别出34个MDD风险SNP破坏15种转录因子的结合。
- eQTL分析识别了可能受这些调控性风险SNP调控的靶基因。
- NEGR1受转录因子结合破坏性MDD风险SNP rs3101339调控,并在MDD患者脑中相比对照表达失调。
临床怎么用
- 研究识别的潜在MDD因果变异及靶基因可作为未来机制研究和药物开发的候选。
- rs3101339可能通过影响NEGR1表达 confer MDD风险,提示NEGR1通路值得进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Major depressive disorder (MDD) is one of the most prevalent psychiatric disorders and a leading cause of disability worldwide. Though recent genome-wide association studies (GWAS) have identified multiple risk variants for MDD, how these variants confer MDD risk remains largely unknown. Here we systematically characterize the regulatory mechanism of MDD risk variants using a functional genomics approach. By integrating chromatin immunoprecipitation sequencing (ChIP-Seq) (from human brain tissues or neuronal cells) and position weight matrix (PWM) data, we identified 34 MDD risk SNPs that disrupt the binding of 15 transcription factors (TFs). We verified the regulatory effect of the TF binding-disrupting SNPs with reporter gene assays, allelic-specific expression analysis, and CRISPR-Cas9-mediated genome editing. Expression quantitative trait loci (eQTL) analysis identified the target genes that might be regulated by these regulatory risk SNPs. Finally, we found that NEGR1 (regulated by the TF binding-disrupting MDD risk SNP rs3101339) was dysregulated in the brains of MDD cases compared with controls, implying that rs3101339 may confer MDD risk by affecting NEGR1 expression. Our findings reveal how genetic variants contribute to MDD risk by affecting TF binding and gene regulation. More importantly, our study identifies the potential MDD causal variants and their target genes, thus providing pivotal candidates for future mechanistic study and drug development.
引用
- Li S, Li Y, Li X, et al. Regulatory mechanisms of major depressive disorder risk variants. Mol Psychiatry. 2020. PMID: 32214206. doi:10.1038/s41380-020-0715-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。